Corteria Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $79M
Investors
- 7
About Corteria Pharmaceuticals
Founded in 2021 and headquartered in Paris, France, Corteria Pharmaceuticals is dedicated to advancing novel therapeutics.Corteria Pharmaceuticals specializes in developing innovative therapeutics aimed at addressing critical unmet medical needs in conditions such as worsening heart failure, sarcopenia, and obesity-related complications. Their primary products COR-1167 and COR-1389 target specific biological pathways involved in fluid retention and cardiac function. The company utilizes methodologies for patient stratification to ensure effective treatment delivery.Corteria Pharmaceuticals generates revenue through strategic partnerships and collaborations with healthcare institutions and research organizations. Their business model relies on securing agreements for clinical trial phases, which include milestone payments tied to clinical development stages and potential royalties from future product sales. They are focused on rolling out new therapies based on their current innovations in the coming years.
Who invested in Corteria Pharmaceuticals
7 investors across 3 rounds
See all investors in Corteria Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Corteria Pharmaceuticals
Who invested in Corteria Pharmaceuticals?
Corteria Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corteria Pharmaceuticals raised?
Corteria Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Corteria Pharmaceuticals last raise money?
Corteria Pharmaceuticals's most recent round on record is a Series A, in Sep 2023.
What does Corteria Pharmaceuticals do?
Founded in 2021 and headquartered in Paris, France, Corteria Pharmaceuticals is dedicated to advancing novel therapeutics.
Where is Corteria Pharmaceuticals headquartered?
Corteria Pharmaceuticals is headquartered in Paris, France.
Which VCs invest in companies like Corteria Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Corteria Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Corteria Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.